Clinical trials
Fatty Liver trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2012 | 1 |
| 2022 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 1 |
| Eli Lilly and Company | 1 |
| Haukeland University Hospital | 1 |
| Helse Stavanger HF | 1 |
| University Hospital, Aker | 1 |
| University Hospital, Akershus | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fatty Liver | 6 |
| Non-alcoholic Fatty Liver Disease | 3 |
| Atherosclerosis | 1 |
| Cardiovascular Diseases | 1 |
| Carotid Stenosis | 1 |
| Fibrosis | 1 |
| Hepatitis | 1 |
| Ischemic Stroke | 1 |
| Liver Diseases | 1 |
| Myocardial Ischemia | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.